📰 Chi Advisors News
Chi Advisors News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Chi Advisors. Real-time updates on events, politics, business and more.
February 22, 2024
CHI Advisors LLC boosted its position in shares of Ikena Oncology, Inc. (NASDAQ:IKNA – Free Report) by 2.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,180,934 shares of the company’s stock after buying an additional 58,894 shares during the period. […]
February 22, 2024
CHI Advisors LLC boosted its holdings in shares of Orchard Therapeutics plc (NASDAQ:ORTX – Free Report) by 1,529.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,315,654 shares of the company’s stock after acquiring an additional 11,559,916 shares during the quarter. Orchard Therapeutics accounts […]
February 22, 2024
CHI Advisors LLC boosted its stake in Ikena Oncology, Inc. (NASDAQ:IKNA – Free Report) by 2.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,180,934 shares of the company’s stock after purchasing an additional 58,894 shares during the quarter. Ikena […]
December 3, 2023
CHI Advisors LLC bought a new position in shares of Acelyrin, Inc. (NASDAQ:SLRN – Free Report) during the 2nd quarter, Holdings Channel.com reports. The firm bought 2,663,806 shares of the company’s stock, valued at approximately $55,674,000. Acelyrin makes up 16.8% of CHI Advisors LLC’s holdings, making the stock its 2nd biggest holding. Other hedge funds […]
December 3, 2023
CHI Advisors LLC acquired a new stake in Acelyrin, Inc. (NASDAQ:SLRN – Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 2,663,806 shares of the company’s stock, valued at approximately $55,674,000. Acelyrin comprises approximately 16.8% of CHI Advisors LLC’s […]
August 25, 2023
CHI Advisors LLC cut its holdings in Freeline Therapeutics Holdings plc (NASDAQ:FRLN – Free Report) by 1.8% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 4,729,419 shares of the company’s stock after selling 85,000 shares during the period. Freeline Therapeutics comprises approximately 0.6% of CHI Advisors […]